Carna Biosciences ROA 2024

Carna Biosciences Aktienanalyse

What does Carna Biosciences do?

Carna Biosciences Inc is a biopharmaceutical company focused on the development, manufacturing, and marketing of innovative drugs for the treatment of serious diseases. The company was founded in Kobe, Japan in 2003 and has quickly become a major player in biomedical research and development. Carna Biosciences Inc's business model is based on the development and marketing of drugs developed through advanced scientific technologies and procedures. The company aims to provide groundbreaking treatments that meet the needs of patients and improve their quality of life. Carna Biosciences has three different business areas focusing on the discovery, development, and manufacturing of therapeutics. The first area is drug research, where the company identifies and characterizes new drug candidates. The second area is drug development, where the company further develops potential drug candidates and conducts clinical trials. The third area is drug manufacturing and marketing, where Carna Biosciences advances the approval and commercialization of drugs in Japan, the United States, and Europe. Carna Biosciences offers a variety of products that can be used for the development of new drugs and research in the fields of biology and pharmacology. These products include kinase inhibitors, proteins, antibodies, enzymes, and reagents for cell analysis. Of particular note are the company's high-quality kinase inhibitors, which can be used for the research of cancer and other diseases. Kinase inhibitors are drugs that inhibit cell growth by blocking the enzyme kinase, which is responsible for cell growth and division. Carna Biosciences has developed a range of kinase inhibitors that show promise in the treatment of cancer, neurodegenerative diseases, and inflammation. Important milestones in the company's history include the establishment of Carna Biosciences USA, Inc. in 2016, further expanding the company's presence in the North American market. Additionally, Carna Biosciences has formed several partnerships with other companies to advance the development and marketing of new therapeutics. Overall, Carna Biosciences has become a major player in the biopharmaceutical industry focused on the development of innovative drugs to combat serious diseases. The company relies on cutting-edge scientific technologies and procedures to develop groundbreaking treatments and improve the quality of life for patients worldwide. Carna Biosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Carna Biosciences's Return on Assets (ROA)

Carna Biosciences's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Carna Biosciences's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Carna Biosciences's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Carna Biosciences’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Carna Biosciences Stock

What is the Return on Assets (ROA) of Carna Biosciences this year?

The Return on Assets (ROA) of Carna Biosciences is -0.27 undefined this year.

What was the ROA of Carna Biosciences compared to the previous year?

The ROA of Carna Biosciences has increased by -16.21% compared to the previous year.

What consequences do high ROA have for investors of Carna Biosciences?

A high ROA is advantageous for investors of Carna Biosciences, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Carna Biosciences?

A low ROA can be unfavorable for investors of Carna Biosciences as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Carna Biosciences affect the company?

An increase in ROA of Carna Biosciences can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Carna Biosciences impact the company?

A reduction in the ROA of Carna Biosciences can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Carna Biosciences?

Some factors that can influence the ROA of Carna Biosciences include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Carna Biosciences important for investors?

The ROA of Carna Biosciences is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Carna Biosciences take to improve ROA?

To improve ROA, Carna Biosciences can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Carna Biosciences pay?

Over the past 12 months, Carna Biosciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Carna Biosciences is expected to pay a dividend of 0 JPY.

What is the dividend yield of Carna Biosciences?

The current dividend yield of Carna Biosciences is .

When does Carna Biosciences pay dividends?

Carna Biosciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Carna Biosciences?

Carna Biosciences paid dividends every year for the past 0 years.

What is the dividend of Carna Biosciences?

For the upcoming 12 months, dividends amounting to 0 JPY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Carna Biosciences located?

Carna Biosciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Carna Biosciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Carna Biosciences from 6/26/2024 amounting to 0 JPY, you needed to have the stock in your portfolio before the ex-date on 6/26/2024.

When did Carna Biosciences pay the last dividend?

The last dividend was paid out on 6/26/2024.

What was the dividend of Carna Biosciences in the year 2023?

In the year 2023, Carna Biosciences distributed 0 JPY as dividends.

In which currency does Carna Biosciences pay out the dividend?

The dividends of Carna Biosciences are distributed in JPY.